CytomX Therapeutics Inc — Balance Sheet (NASDAQ:CTMX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 358.66 M339.41 M260.89 M201.79 M120.53 M Total liabilities 308.86 M250.03 M346.64 M249.24 M120.99 M Total equity 49.8 M89.38 M85.75 M47.45 M456 K Total liabilities & shareholders' equities 358.66 M339.41 M260.89 M201.79 M120.53 M Total debt ————— Net debt —————

Haberler

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

CytomX Guggenheim Zirvesi’nde: Umut Verici Kolorektal Kanser Tedavi Yolu

CytomX at Guggenheim Summit: Promising CRC Treatment Path

Qiagen (QGEN) Meets Q4 Earnings Estimates

CytomX Therapeutics stock hits 52-week high at 6.16 USD

Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?

Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?

Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data

CytomX Stock Rises 31% in a Month: Here's What You Should Know

CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX)